Clinical Roundup Interim phase II results show positive safety and efficacy data for bel-sar in early-stage choroidal melanoma February 17, 2023Vol.49 No.07
Clinical Roundup Moffitt researchers discover pathways to activate dendritic cells, produce strong anti-tumor immunity February 17, 2023Vol.49 No.07
Clinical Roundup NY Proton Center initiates three studies on FLASH radiation therapy February 17, 2023Vol.49 No.07
Clinical Roundup Lung cancer study finds new target for treatment resistance after EGFR inhibitors February 17, 2023Vol.49 No.07
Clinical Roundup Research reveals why cancers stop responding to kinase-blocking drugs February 17, 2023Vol.49 No.07
Clinical Roundup Keytruda + chemo met primary endpoint as first-line therapy for advanced or recurrent endometrial carcinoma February 10, 2023Vol.49 No.06
Clinical Roundup Oncolytic virus treatment produces promising results for TNBC in phase II study February 10, 2023Vol.49 No.06
Clinical Roundup Uncertainty about breast cancer risk and screening choices increase with breast density awareness February 10, 2023Vol.49 No.06
Clinical Roundup Wistar scientists identify gene signature to assess cancer risk February 10, 2023Vol.49 No.06
Clinical Roundup Blood pressure drug may prevent immunotherapy-induced brain swelling in patients with glioblastoma February 10, 2023Vol.49 No.06
